The Return of NRICM101 to Taiwan: The Contributions of an Herbal Formula to Both COVID-19 Treatment and Nationalism

Po-Hsun Chen

Research output: Chapter in Book/Conference proceedingChapterpeer-review

Abstract

This chapter discusses the inaccessibility in Taiwan of the Taiwanese-made herbal formula NRICM101 at the start of the COVID-19 pandemic. Despite being exported overseas, NRICM101 was not available domestically until May 2021, when it was granted Emergency-Use Authorization (EUA) by the Taiwanese government. Drawing on the concepts of classification and sociotechnical imaginaries, this chapter argues that NRICM101 was not only a herbal formula for treating COVID-19 but also a tonic for boosting Taiwan’s nationalism. NRICM101 highlights the disputed regulatory culture of Taiwan’s two-track system, which includes one track for biomedicine and another for traditional Chinese medicine. Despite attracting criticism from medical experts, NRICM101 promoted Taiwanese national identity by presenting itself as the “the glory of Taiwan” and by shifting away from Traditional Chinese Medicine and toward Taiwanese Chinese medicine. Ultimately, NRICM101 showcased Taiwan as a nation independent of China.
Original languageEnglish
Title of host publicationTaiwan’s COVID-19 Experience
Subtitle of host publicationGovernance, Governmentality, and the Global Pandemic
EditorsMing-Cheng M. Lo, Yu-Yueh Tsai, Michael Shiyung Liu
Place of PublicationAbingdon
PublisherRoutledge
Chapter10
Pages227-247
Number of pages21
ISBN (Electronic)9781003438380
ISBN (Print)9781032572208, 9781032572215
DOIs
Publication statusAccepted/In press - Jun 2024

Publication series

NameRoutledge Research on Taiwan
PublisherRoutledge

Fingerprint

Dive into the research topics of 'The Return of NRICM101 to Taiwan: The Contributions of an Herbal Formula to Both COVID-19 Treatment and Nationalism'. Together they form a unique fingerprint.

Cite this